MedPath

COMPARISON OF INTRAVENOUS PALONOSETRON, DEXAMETHASONE AND THEIR COMBINATION AS ANTIEMETIC THERAPY IN LAPAROSCOPIC SURGERIES

Not Applicable
Conditions
Health Condition 1: null- Adult ASA Grade I or II patients of either sex, aged 18 to 60 years, who underwent elective laparoscopic surgeries undergeneral anaesthesia.
Registration Number
CTRI/2016/07/007108
Lead Sponsor
Dr Neha Sadhoo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Adult ASA Grade I or II patients, who underwent elective laparoscopic surgeries under

general anaesthesia.

Exclusion Criteria

1. Pregnant or lactating females

2. Patients older than 60 years or younger than 18 years of age

3. Patients with a history of central nervous system or neuromuscular disease

4. Patients with ASA physical status grade > II

5. Morbidly obese patients

6. Patients with hepatic, renal or cardio-respiratory disease

7. Patients with gastro-esophageal reflux

8. Patients with history of drug or alcohol abuse

9. Patients with known hypersensitivity to either Palonosetron or Dexamethasone

10. Patients with previous history of PONV or motion sickness

11. Patients receiving chemotherapy or radiotherapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Incidence of PONV- using a 3- point scale ( 0-none, 1-nausea, 2- <br/ ><br>vomiting ). <br/ ><br>2. Number of patients needing rescue antiemetic treatment. <br/ ><br>3. Pain intensity scores- obtained with VAS test.Timepoint: 0, l, 2, 4, 8 and <br/ ><br>24 hours
Secondary Outcome Measures
NameTimeMethod
1. Heart rate <br/ ><br>2. Blood pressure <br/ ><br>3. Respiratory rate <br/ ><br>4. Incidence of nausea and vomiting <br/ ><br>5. Visual analogue scale scoreTimepoint: 0, l, 2, 4, 8 and <br/ ><br>24 hours
© Copyright 2025. All Rights Reserved by MedPath